Risk Stratification in Non-ST-segment Elevation Acute Coronary Syndromes: Troponin Alone Is not Enough - 12/08/11
Doi : 10.1016/j.amjmed.2008.07.029
El texto completo de este artículo está disponible en PDF.
El texto completo de este artículo está disponible en PDF.
| Funding: The GRACE registry is funded by a research grant from sanofi-aventis. |
|
| Conflict of interest: Dr. Steg reports having received honoraria as speaker or consultant from Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS, Endotis, GSK, Medtronic, MSD, Nycomed, sanofi-aventis, Servier, The Medicines Company. In addition, his institution has received a research grant from sanofi-aventis in the past 7 years. Dr. FitzGerald has no disclosures. Dr. Fox reports having received honoraria as speaker or consultant and research grants from Sanofi-aventis, GSK and Merck, Sharpe and Dohme. |
|
| Authorship: All authors had access to the data and a role in writing the manuscript. |
© 2009
Elsevier Inc. Reservados todos los derechos.
Vol 122 - N° 2
P. 107-108 - février 2009 Regresar al número
Artículo precedente
- Premed Requirements: The Time for Change Is Long Overdue!
- James E. Dalen, Joseph S. Alpert
- Asthma in US Seniors: Part 2. Treatment. Seeing Through the Glass Darkly
- Richard D. deShazo, J. Eric Stupka
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?